Global Outcomes for Microsurgical Clipping of Unruptured Intracranial Aneurysms: A Benchmark Analysis of 2245 Cases
Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
DREXLER, Richard
SAUVIGNY, Thomas
PANTEL, Tobias F.
RICKLEFS, Franz L.
CATAPANO, Joshua S.
WANEBO, John E.
LAWTON, Michael T.
SANCHIN, Aminaa
HECHT, Nils
VAJKOCZY, Peter
Citação
NEUROSURGERY, v.94, n.2, p.369-378, 2024
Resumo
BACKGROUND AND OBJECTIVES: Benchmarks represent the best possible outcome and help to improve outcomes for surgical procedures. However, global thresholds mirroring an optimal and reachable outcome for microsurgical clipping of unruptured intracranial aneurysms (UIA) are not available. This study aimed to define standardized outcome benchmarks in patients who underwent clipping of UIA. METHODS: A total of 2245 microsurgically treated UIA from 15 centers were analyzed. Patients were categorized into low- (""benchmark"") and high-risk (""nonbenchmark"") patients based on known factors affecting outcome. The benchmark was defined as the 75th percentile of all centers' median scores for a given outcome. Benchmark outcomes included intraoperative (eg, duration of surgery, blood transfusion), postoperative (eg, reoperation, neurological status), and aneurysm-related factors (eg, aneurysm occlusion). Benchmark cutoffs for aneurysms of the anterior communicating/anterior cerebral artery, middle cerebral artery, and posterior communicating artery were determined separately. RESULTS: Of the 2245 cases, 852 (37.9%) patients formed the benchmark cohort. Most operations were performed for middle cerebral artery aneurysms (53.6%), followed by anterior communicating and anterior cerebral artery aneurysms (25.2%). Based on the results of the benchmark cohort, the following benchmark cutoffs were established: favorable neurological outcome (modified Rankin scale <= 2) >= 95.9%, postoperative complication rate <= 20.7%, length of postoperative stay <= 7.7 days, asymptomatic stroke <= 3.6%, surgical site infection <= 2.7%, cerebral vasospasm <= 2.5%, new motor deficit <= 5.9%, aneurysm closure rate >= 97.1%, and at 1-year follow-up: aneurysm closure rate >= 98.0%. At 24 months, benchmark patients had a better score on the modified Rankin scale than nonbenchmark patients. CONCLUSION: This study presents internationally applicable benchmarks for clinically relevant outcomes after microsurgical clipping of UIA. These benchmark cutoffs can serve as reference values for other centers, patient registries, and for comparing the benefit of other interventions or novel surgical techniques.
Palavras-chave
Aneurysm, UIA, Outcome, Clipping, Microsurgery, Microsurgical
Referências
- Algra AM, 2019, JAMA NEUROL, V76, P282, DOI 10.1001/jamaneurol.2018.4165
- Barkun J, 2023, JAMA SURG, V158, P341, DOI 10.1001/jamasurg.2022.5831
- Bekelis K, 2014, J NEUROSURG, V120, P591, DOI 10.3171/2013.8.JNS13228
- Bhatia S, 2011, ACTA NEUROCHIR, V153, P905, DOI 10.1007/s00701-010-0846-8
- Brown RD, 2014, LANCET NEUROL, V13, P393, DOI 10.1016/S1474-4422(14)70015-8
- Dasenbrock HH, 2018, J NEUROSURG, V128, P756, DOI 10.3171/2016.10.JNS161810
- Etminan N, 2022, EUR STROKE J, V7, pV, DOI 10.1177/23969873221099736
- Etminan N, 2016, NAT REV NEUROL, V12, P699, DOI 10.1038/nrneurol.2016.150
- Gaub M, 2023, J CLIN NEUROSCI, V107, P178, DOI 10.1016/j.jocn.2022.10.010
- Gero D, 2022, ANN SURG, V275, P115, DOI 10.1097/SLA.0000000000003931
- Goertz L, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-14945-w
- Golnari P, 2021, J NEUROSURG, V134, P848, DOI 10.3171/2019.12.JNS192755
- Hackenberg KAM, 2018, STROKE, V49, P2268, DOI 10.1161/STROKEAHA.118.021030
- Hoffman H, 2019, WORLD NEUROSURG, V128, pE873, DOI 10.1016/j.wneu.2019.05.021
- Huang MC, 2011, STROKE, V42, P1730, DOI 10.1161/STROKEAHA.110.603803
- Juvela S, 2001, STROKE, V32, P485, DOI 10.1161/01.STR.32.2.485
- Kerezoudis P, 2016, CLIN NEUROL NEUROSUR, V149, P75, DOI 10.1016/j.clineuro.2016.07.027
- KING JT, 1994, J NEUROSURG, V81, P837, DOI 10.3171/jns.1994.81.6.0837
- Kotowski M, 2013, J NEUROL NEUROSUR PS, V84, P42, DOI 10.1136/jnnp-2011-302068
- Krag CH, 2021, J NEUROL SCI, V422, DOI 10.1016/j.jns.2021.117338
- Mason AM, 2009, J KOREAN NEUROSURG S, V45, P133, DOI 10.3340/jkns.2009.45.3.133
- McCutcheon BA, 2016, WORLD NEUROSURG, V91, P272, DOI [10.1016/J.WNEU.2016.04.039, 10.1016/j.wneu.2016.04.039]
- McDonald JS, 2013, STROKE, V44, P988, DOI 10.1161/STROKEAHA.111.000196
- Muller X, 2018, ANN SURG, V267, P419, DOI 10.1097/SLA.0000000000002477
- Naggara ON, 2010, RADIOLOGY, V256, P887, DOI 10.1148/radiol.10091982
- Pierot L, 2023, J NEUROINTERV SURG, V15, P552, DOI 10.1136/neurintsurg-2021-018414
- Raaymakers TWM, 1998, STROKE, V29, P1531, DOI 10.1161/01.STR.29.8.1531
- Raptis DA, 2020, ANN SURG, V272, P731, DOI 10.1097/SLA.0000000000004267
- Raptis DA, 2019, ANN SURG, V270, P835, DOI 10.1097/SLA.0000000000003539
- Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9
- Sánchez-Velázquez P, 2019, ANN SURG, V270, P211, DOI 10.1097/SLA.0000000000003223
- Smith TR, 2015, WORLD NEUROSURG, V84, P942, DOI 10.1016/j.wneu.2015.05.073
- Staiger RD, 2019, BRIT J SURG, V106, P59, DOI 10.1002/bjs.10976
- Szelényi A, 2011, CLIN NEUROL NEUROSUR, V113, P129, DOI 10.1016/j.clineuro.2010.10.012
- Tang AB, 2020, SURGERY, V167, P550, DOI 10.1016/j.surg.2019.11.013
- Tsutsumi K, 2001, STROKE, V32, P1191, DOI 10.1161/01.STR.32.5.1191
- Tykocki T, 2014, ACTA NEUROCHIR, V156, P861, DOI 10.1007/s00701-014-2006-z
- van der Kamp LT, 2021, JAMA NEUROL, V78, P1228, DOI 10.1001/jamaneurol.2021.2915
- Villablanca JP, 2013, RADIOLOGY, V269, P258, DOI 10.1148/radiol.13121188
- Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0
- von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040297, 10.1016/S0140-6736(07)61602-X]
- Walendy V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012294
- Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd
- Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
- Zhang XX, 2018, WORLD NEUROSURG, V115, P393, DOI 10.1016/j.wneu.2018.04.028